Stocks · Health care · Pharmaceutical Preparations

INSMED Inc

INSM Clue Score46
United States Fiscal year ends December CIK 0001104506 Results filed 29 Oct 2026

What the insiders did Net selling

By person

27 insiders · 633 transactions
71.5×

William H. Lewis holds 71.5 times base salary in stock. $61.13M of shares against $854.55K in salary for 2025.

Salary from the company's own proxy. The shares are what William H. Lewis last reported holding, valued at $124.00, the price Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
William Lewis
Chair and CEO
$249.60K (1)
$121.53M (218) scheduled
−$121.28M
492,982
0.2257%
$61.13M
—
Martina M.D. Flammer
Chief Medical Officer
—
$86.69M (88) scheduled
−$86.69M
60,486
0.0277%
$7.50M
—
Orlov S Nicole Schaeffer
Chief People Strategy Officer
—
$69.85M (63) scheduled
−$69.85M
41,754
0.0191%
$5.18M
+520.0%
Roger Adsett
Chief Operating Officer
$47.91K (1)
$62.71M (45) scheduled
−$62.66M
98,744
0.0452%
$12.24M
+2,347%
Sara Bonstein
Chief Financial Officer
—
$44.19M (39) scheduled
−$44.19M
69,082
0.0316%
$8.57M
+1,620%
Michael Alexander Smith
Chief Legal Officer
—
$33.12M (58) scheduled
−$33.12M
37,648
0.0172%
$4.67M
+44.8%
Leo Lee
Director
$796.05K (1)
$14.69M (5)
−$13.90M
57,971
0.0265%
$7.19M
+480.3%
Melvin Md Sharoky
Director
$1.58M (8)
$11.16M (16)
−$9.58M
246,081
0.1127%
$30.51M
+1.7%
Christine A Pellizzari
Chief Legal Officer
$407.48K (4)
$7.94M (19) scheduled
−$7.54M
149,985
0.0687%
$18.60M
+3,786%
John Soriano
Chief Compliance Officer
—
$4.85M (7) scheduled
−$4.85M
35,204
0.0161%
$4.37M
+1,182%
John Drayton Wise
Chief Commercial Officer
—
$3.03M (20) scheduled
−$3.03M
133,015
0.0609%
$16.49M
+142.2%
Elizabeth M Anderson
Director
—
$2.98M (2)
−$2.98M
62,034
0.0284%
$7.69M
—
David R Brennan
Director
$301.50K (1)
$3.10M (1)
−$2.80M
159,238
0.0729%
$19.75M
+66.6%
Donald J Hayden Jr
Director
—
$2.45M (7) scheduled
−$2.45M
62,197
0.0285%
$7.71M
+25.8%
Alfred Altomari
Director
—
$1.37M (5)
−$1.37M
69,495
0.0318%
$8.62M
+97.6%
Andrew T Drechsler
Chief Financial Officer
—
$990.35K (3) scheduled
−$990.35K
15,000
0.0069%
$1.86M
—
Steinar J Engelsen
Director
$783.04K (3)
—
+$783.04K
320,802
0.1469%
$39.78M
+27.1%
John Goll
Chief Accounting Officer
—
$501.00K (1) scheduled
−$501.00K
14,166
0.0065%
$1.76M
+55.5%
David W J McGirr
Director
—
$451.54K (2) scheduled
−$451.54K
97,723
0.0447%
$12.12M
+332.5%
Clarissa Desjardins
Director
$201.69K (2)
—
+$201.69K
73,337
0.0336%
$9.09M
—
Myrtle S Potter
Director
—
$82.73K (2)
−$82.73K
25,510
0.0117%
$3.16M
+32.8%
Carol Schafer
Director
—
—
—
66,622
0.0305%
$8.26M
—
Paul Streck
Chief Medical Officer
—
—
—
15,996
0.0073%
$1.98M
—
Paolo Tombesi
Chief Financial Officer
—
—
—
10,669
0.0049%
$1.32M
—
Samuele Butera
SVP, GM, Global Respiratory
—
—
—
7,342
0.0034%
$910.41K
—
Utpal Koppikar
Director
—
—
—
6,139
0.0028%
$761.24K
—
Paul Hudson
Director
—
—
—
6,139
0.0028%
$761.24K
—